These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38758224)

  • 1. [Deprescribing in DGPPN S3 guidelines-a systematic analysis].
    Seitz S; Hasan A; Strube W; Wagner E; Leucht S; Halms T
    Nervenarzt; 2024 May; ():. PubMed ID: 38758224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychosocial therapy in psychiatry : Update of the DGPPN-S3 guidelines "Psychosocial therapies for severe mental illnesses"].
    Gühne U; Weinmann S; Becker T; Riedel-Heller SG
    Nervenarzt; 2020 Nov; 91(11):993-1002. PubMed ID: 32725490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The German S3 guidelines on prevention of coercion and treatment of aggressive behavior: from evidence to consensus, from consensus to implementation].
    Steinert T; Hirsch S
    Nervenarzt; 2023 Jul; 94(7):614-618. PubMed ID: 36939857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations].
    Hasan A; Falkai P; Lehmann I; Janssen B; Wobrock T; Zielasek J; Gaebel W
    Nervenarzt; 2020 Jan; 91(1):26-33. PubMed ID: 31605161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN)].
    Wobrock T; Schneider F; Falkai P
    Nervenarzt; 2010 Sep; 81(9):1041-8. PubMed ID: 20798916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [German S3 guidelines on avoidance of coercion: prevention and therapy of aggressive behavior in adults].
    Steinert T; Hirsch S
    Nervenarzt; 2020 Jul; 91(7):611-616. PubMed ID: 31473766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of evidence grades in psychiatry and psychotherapy guidelines.
    Löhrs L; Handrack M; Kopp I; Jessen F; Wagner E; Falkai P; Röh A; Strube W; Hasan A
    BMC Psychiatry; 2020 Oct; 20(1):503. PubMed ID: 33046040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methodology of the S3 guidelines on alcohol and tobacco-related disorders].
    Hoch E; Petersen K; Kopp I; Batra A; Mann K
    Nervenarzt; 2016 Jan; 87(1):6-12. PubMed ID: 26678625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.
    Farrell B; Pottie K; Rojas-Fernandez CH; Bjerre LM; Thompson W; Welch V
    PLoS One; 2016; 11(8):e0161248. PubMed ID: 27517450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The German S3 guidelines on dementia].
    Jessen F; Bohr L; Kruse C; Dodel R
    Nervenarzt; 2023 Jul; 94(7):609-613. PubMed ID: 37233772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychosocial therapies in severe mental illness: DGPPN-S3-guideline: evidence, recommendations and challenges for mental health service research].
    Riedel-Heller SG; Gühne U; Weinmann S; Becker T;
    Psychother Psychosom Med Psychol; 2012 Nov; 62(11):425-8. PubMed ID: 23143829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy].
    Hasan A; Wobrock T; Gaebel W; Janssen B; Zielasek J; Falkai P; ;
    Nervenarzt; 2013 Nov; 84(11):1359-60, 1362-4, 1366-8. PubMed ID: 24077969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines.
    Preuss UW; Gouzoulis-Mayfrank E; Havemann-Reinecke U; Schäfer I; Beutel M; Hoch E; Mann KF
    Eur Arch Psychiatry Clin Neurosci; 2018 Apr; 268(3):219-229. PubMed ID: 28439723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do clinical practice guidelines say about deprescribing? A scoping review.
    Langford AV; Warriach I; McEvoy AM; Karaim E; Chand S; Turner JP; Thompson W; Farrell BJ; Pollock D; Moriarty F; Gnjidic D; Ailabouni NJ; Reeve E
    BMJ Qual Saf; 2024 May; ():. PubMed ID: 38789258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing recommendations: An essential consideration for clinical guideline developers.
    Moriarty F; Pottie K; Dolovich L; McCarthy L; Rojas-Fernandez C; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):806-810. PubMed ID: 30241877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].
    Voderholzer U; Favreau M; Rubart A; Staniloiu A; Wahl-Kordon A; Zurowski B; Kathmann N
    Nervenarzt; 2022 Jul; 93(7):678-687. PubMed ID: 35763051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comment on the S3 Guidelines Dementia by the DGPPN and the DGN from the neurological point of view].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2010 Sep; 78(9):504-8. PubMed ID: 20827649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Developmental process of DGPPN quality indicators].
    Großimlinghaus I; Falkai P; Gaebel W; Janssen B; Reich-Erkelenz D; Wobrock T; Zielasek J
    Nervenarzt; 2013 Mar; 84(3):350-65. PubMed ID: 23494246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline-conform psychiatric psychotherapeutic treatment for patients with schizophrenia : A normative evaluation of necessary personnel requirements].
    Mehl S; Falkai P; Berger M; Löhr M; Rujescu D; Wolff J; Kircher T
    Nervenarzt; 2016 Mar; 87(3):286-94. PubMed ID: 26820457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychosocial interventions in severe mental illness: evidence and recommendations: psychoeducation, social skill training and exercise].
    Riedel-Heller SG; Gühne U; Weinmann S; Arnold K; Ay ES; Becker T
    Nervenarzt; 2012 Jul; 83(7):847-54. PubMed ID: 22729513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.